fda glp 1 green list FDA's List: A Step in the Right Direction for Patient Safety FDA introduces "Green List" for

But, as always happens with big pharma blockbusters, the research community is busy exploring other possible applications for this class of compounds, with clinical trials underway or forming in cardiovascular disease, chronic kidney disease and obstructive sleep apnea

Christopher McGowan, an obesity medicine physician and founder of True You Weight Loss in Cary, North Carolina, previously told TODAY.com

Sources Asano, D., Takakusa, H., & Nakai, D

Current Neuropharmacology 2016 Sikiri et al

Gopal Grandhige, MD, a board-certified general surgeon specializing in aesthetic surgery, integrates peptide therapy into broader treatment plans when appropriate